ICMT-DT and breast cancer: Further in vitro and in vivo analysis revealed that Linc00337 not only enhances the malignant phenotype of breast cancer cells but also promotes chemoresistance to the chemotherapeutic drug paclitaxel [31] through M2-like macrophages [26], which are considered to interact with tumor cells and promote tumor development [32,33,34].